NeuroNEXT

Kolb SJ, Coffey CS, Yankey JW, Krosschell K, Arnold WD, Rutkove SB, Swoboda KJ, Reyna SP, Sakonju A, Darras BT, Shell R, Kuntz N, Castro D, Iannaccone ST, Parsons J, Connolly AM, Chiriboga CA, McDonald C, Burnette WB, Werner K, Thangarajh M, Shieh PB, Finanger E, Cudkowicz ME, McGovern MM, McNeil DE, Finkel R, Kaye E, Kingsley A, Renusch SR, McGovern VL, Wang X, Zaworski PG, Prior TW, Burghes AH, Bartlett A, Kissel JT; NeuroNEXT Clinical Trial Network and on behalf of the NN101 SMA Biomarker Investigators.

Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study.

PubMed: PMC4748311

Fox RJ, Coffey CS, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Conwit R, Naismith R, Ashokkumar A, Bermel R, Ecklund D, Koepp M, Long J, Natarajan S, Ramachandran S, Skaramagas T, Thornell B, Yankey J, Agius M, Bashir K, Cohen B, Coyle P, Delgado S, Dewitt D, Flores A, Giesser B, Goldman M, Jubelt B, Lava N, Lynch S, Miravalle A, Moses H, Ontaneda D, Perumal J, Racke M, Repovic P, Riley C, Severson C, Shinnar S, Suski V, Weinstock-Gutman B, Yadav V, Zabeti A.

Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.

PubMed: PMC5035622

Lyden P, Weymer S, Coffey C, Cudkowicz M, Berg S, O’Brien S, Fisher M, Haley EC, Khatri P, Saver J, Levine S, Levy H, Rymer M, Wechsler L, Jadhav A, McNeil E, Waddy S, Pryor K.

Selecting patients for intraarterial therapy in the context of a clinical trial for neuroprotection.

PubMed: PMC5134840

Kaufmann P, O’Rourke PP.

Central Institutional Review Board Review for an Academic Trial Network

PubMed: PMC4859204

Coffey CS.

You May Have Worked on More Adaptive Designs Than You Think

PubMed: PMC4308449

Ullman K.

A burst of speed for neurological research

PubMed:

Kairalla JA, Coffey CS, Thomann MA, Muller KE.

Adaptive trial designs: A review of barriers and opportunities

PubMed: PMC3519822

Editorial

NeuroNEXT: accelerating drug development in Neurology

PubMed:

Dolgin E.

Trial Networks Move Beyond Single-Disease Strategies.

PubMed: